Search Results

Gain Therapeutics, Inc., (Nasdaq: GANX) (“Gain”, or the “Company”) today announced that Matthias Alder, Chief Executive Officer of Gain Therapeutics, will deliver a featured presentation at the Cambridge Healthtech Institute’s 2nd Annual Neurodegeneration Targets Conference: Drug Discovery for Progressive Central Nervous System Disorders.

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase) today announced that Milton Werner, Ph.D., President and Chief Executive Officer of Inhibikase, will present at the Cambridge Healthtech Institute’s Inaugural Neurodegeneration Targets: Drug Discovery for Brain and Nerve-Related Progressive Disorders Conference.

Rapafusyn Pharmaceuticals is pleased to announce two upcoming presentations at Cambridge Health Institute’s 12th Annual Oral Peptides & Macrocyclics Conference, April 1 – 4 in San Diego.

Aligos Therapeutics, Inc. today announced that the Company will make an oral presentation at the Cambridge Healthtech Institute’s 20th Annual Discovery on Target Conference being held October 17-20, 2022 in Boston, MA.

Berkeley Lights, Inc., a leader in digital cell biology, announced its participation at the Cambridge Healthtech Institute’s 14th Annual Bioprocessing Summit being held from August 15 - 18, 2022, virtually and at the Sheraton Boston in Boston, Massachusetts.

Healthtech company Entia is one of the stars of a new series of video shorts produced by the Association of British HealthTech Industries (ABHI)

HCW Biologics Inc. announced that Hing C. Wong, Ph.D., Founder and CEO of HCW Biologics, will speak at the Cambridge Healthtech Institute’s 24th Annual PepTalk Conference to be held on January 17-19, 2022.

The new Cambridge, Mass.–based facility is about 460,000 square feet. Labs occupy nearly 50% of the space.